🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

On March 30, during virtual Ansys SimCare Conf, Antleron CEO Jan Schrooten will join @prithbanarjee (CTO, Ansys) for 11 AM 'The process to Adopt & Deploy' Session. More info & register now 👉 bit.ly/3tABf2n #computationalmodeling #flowsimulation #pharma #bioprocess

Blogpost on how we apply 3D printing in R&D projects. Additive Manufacturing offers flexibility to fast-track & scale design & dev. of custom solutions for cell & gene therapy & diagnostics markets 👉 lnkd.in/datfN4NQ #3dprinting #additivemanufacturing #bioprocess

Customized 3D bioreactors are essential in helping produce huge numbers of cells. Using 3D printing as part of Antleron toolbox, we enable bioprocess solutions by developing customized fixed beds that result in scalable & sustainable cell processing 👉 bit.ly/3uJUkQs

Our Antleron Fellows contributed to the 3rd edition of 'Tissue Engineering', a well-received handbook originally published in 2014 (Elsevier). They explain how #tissueengineering manufacturing becomes sustainable & scalable 👉 bit.ly/3L4IULR #bioprocess @uqui_5

Happy to announce that Jan Schrooten, CEO Antleron, joins MEDVIA as member of the Board of Directors. MEDVIA is newly established #FlandersHealthTech innovation cluster 👉 lnkd.in/eWT5YPG9 #biotechnology #grants #cluster #ecosystem #digitalhealth #medicaltechnology

.Antleron was invited to join today SME BioForum organized by EuropaBio. Focus : Advanced Therapy Medicinal Products (ATMP) in Europe & how the #regulatory & market access landscape influences their availability to the patients 👉 bit.ly/3a9brTG #cellandgenetherapy

Meet KU Leuven professor Rik Gijsbers. Rik talks about his motivations to become a scientist. And why he decided to take a step into industry by joining Antleron as consultant, strengthening our Labatman expertise 👉 bit.ly/3NiereC #viralvecor #genetherapy #celltherapy

At the Infinite-Ansys User Meeting in #Eindhoven on Oct. 14, Antleron CEO Jan Schrooten will present an inspiring testimonial on the innovative deployment of in-silico tools as part of a digital twin 👉 bit.ly/3RW3cdU #simulation #insilico #digitaltwins #hybridmodels

Together with our partners at myNEO, VUB, and QbD group, we work on the future of #cancervaccines. Persomed aims to help treat tumors unresponsive to other treatment modalities by offering a novel, personalized cancer vaccine. Read BioVox article bit.ly/3XFNub8

The 3rd edition of the Tissue Engineering Handbook is out! Our colleagues contributed to the chapter Product and process design: scalable and sustainable tissue-engineered product manufacturing. Read now 👉 bit.ly/3L4IULR #tissueengineering #bioprocesses #atmp

Antleron's end of the year newsletter is out! -> bit.ly/3HMgZm0 It talks about new ideas, collaborations & projects, all together bringing more personalized healthcare closer and faster to patients. Stay updated on Antleron? 👉 lnkd.in/dKvTr2Zx

Kick off 2023... 'Life on Chip' will return as 'HealthTech Summit' in Leuven! The 5th edition examines the current state & collaborative innovation, and we co-organize for 5th time! Check cross-over innovations in #medicine & #health 👉 bit.ly/3Q85rvn MEDVIA

More happy 2023 news that give us a boost to keep working hard on #healthcare innovations! Proud to share that Antleron is nominated for 2023 Flemish-Brabant Trends Gazellen award. More on Antleron 👉 antleron.com More on Trends Gazellen 👉 trendsgazellen.be

According to @trends_be magazine, Antleron ranks Nr. 8 among fastest growing small enterprises in Flemish-Brabant! Our nomination signals that our collaborative development model gains traction in #biotech 👉 antleron.com #belgium #entrepreneurship #celltherapy

Finally introducing Maarten Sonnaert, Antleron's first employee & currently chief of operations. In this Fellow Friday, Maarten explains how he arrived on his pioneering & entrepreneurial journey 👉 bit.ly/3KgeBDz #bioprocess #sustainable #personalizedmedicine

Dieter Hauwaerts brings strategic & operational ATMP excellence to the Antleron team. He is co-founder of Antleron and has acquired an impressive track record with leading pharma & biotech companies 👉 Full story bit.ly/43DCIEh #bioprocess #celltherapy #genetherapy

It was great to exhibit together with #comate at Knowledge for Growth 2023 in Antwerp. We were thrilled to showcase our collaborative Biodevice-CRO offering materialized in a real-life demonstrator (see image) 👉 bit.ly/461FJjX #KFG2023 flanders.bio ICsense #biotech

Seeking GET-IN PhD candidates to advance gene therapies production: 1) Viral vector production: tackle bottlenecks in efficiency & reproducibility 2) Digital twin & multi-parametric optimization of upstream unit operations for rAAV manufacturing 👉 bit.ly/44J2rwa

Our #AstroCardia participation was picked up by media & supporting organizations (VLAIO #FlandersSpace MEDVIA). Watch coverages in Dutch bit.ly/45TadUP French bit.ly/3PDP9f7 English bit.ly/3Lq67eJ #space #heart #ageing #organoids #bioprocesses

Recently we attended the first edition of the Advanced Therapies Summit in Leuven. At @Antleron we are ready to collaborate & enhance our ecosystem’s resilience for the benefit of patients #atmp #advancedtherapies #celltherapies #genetherapies #tissueengineering #bioprocessing